Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 08:34:04 GMT 2025
by
admin
on
Wed Apr 02 08:34:04 GMT 2025
|
| Protein Type | VIRAL STRUCTURAL PROTEIN |
| Protein Sub Type | VIRAL ENVELOPE PROTEIN |
| Sequence Origin | VIRAL |
| Sequence Type | COMPLETE |
| Record UNII |
8R39BE7TJJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8R39BE7TJJ
Created by
admin on Wed Apr 02 08:34:04 GMT 2025 , Edited by admin on Wed Apr 02 08:34:04 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_1069 | 1_1113 |
| 3_1069 | 3_1113 |
| 2_1069 | 2_1113 |
| 1_1019 | 1_1030 |
| 3_1019 | 3_1030 |
| 2_1019 | 2_1030 |
| 1_827 | 1_838 |
| 3_827 | 3_838 |
| 2_827 | 2_838 |
| 1_730 | 1_736 |
| 3_730 | 3_736 |
| 2_730 | 2_736 |
| 1_725 | 1_747 |
| 3_725 | 3_747 |
| 2_725 | 2_747 |
| 1_649 | 1_658 |
| 3_649 | 3_658 |
| 2_649 | 2_658 |
| 1_604 | 1_636 |
| 3_604 | 3_636 |
| 2_604 | 2_636 |
| 1_525 | 1_577 |
| 3_525 | 3_577 |
| 2_525 | 2_577 |
| 1_467 | 1_475 |
| 3_467 | 3_475 |
| 2_467 | 2_475 |
| 1_378 | 1_512 |
| 3_378 | 3_512 |
| 2_378 | 2_512 |
| 1_366 | 1_419 |
| 3_366 | 3_419 |
| 2_366 | 2_419 |
| 1_323 | 1_348 |
| 3_323 | 3_348 |
| 2_323 | 2_348 |
| 1_278 | 1_288 |
| 3_278 | 3_288 |
| 2_278 | 2_288 |
| 1_118 | 1_153 |
| 3_118 | 3_153 |
| 2_118 | 2_153 |
| 1_2 | 1_123 |
| 3_2 | 3_123 |
| 2_2 | 2_123 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_4 |
| N | 1_48 |
| N | 1_61 |
| N | 1_109 |
| N | 1_136 |
| N | 1_152 |
| N | 1_221 |
| N | 1_269 |
| N | 1_318 |
| N | 1_330 |
| N | 1_590 |
| N | 1_603 |
| N | 1_644 |
| N | 1_696 |
| N | 1_704 |
| N | 1_788 |
| N | 1_1061 |
| N | 1_1085 |
| N | 1_1121 |
| N | 1_1145 |
| N | 1_1160 |
| N | 1_1181 |
| N | 2_4 |
| N | 2_48 |
| N | 2_61 |
| N | 2_109 |
| N | 2_136 |
| N | 2_152 |
| N | 2_221 |
| N | 2_269 |
| N | 2_318 |
| N | 2_330 |
| N | 2_590 |
| N | 2_603 |
| N | 2_644 |
| N | 2_696 |
| N | 2_704 |
| N | 2_788 |
| N | 2_1061 |
| N | 2_1085 |
| N | 2_1121 |
| N | 2_1145 |
| N | 2_1160 |
| N | 2_1181 |
| N | 3_4 |
| N | 3_48 |
| N | 3_61 |
| N | 3_109 |
| N | 3_136 |
| N | 3_152 |
| N | 3_221 |
| N | 3_269 |
| N | 3_318 |
| N | 3_330 |
| N | 3_590 |
| N | 3_603 |
| N | 3_644 |
| N | 3_696 |
| N | 3_704 |
| N | 3_788 |
| N | 3_1061 |
| N | 3_1085 |
| N | 3_1121 |
| N | 3_1145 |
| N | 3_1160 |
| N | 3_1181 |
| O | 1_310 |
| O | 1_312 |
| O | 2_310 |
| O | 2_312 |
| O | 3_310 |
| O | 3_312 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
LIGAND->TARGET |
|
||
|
|
INHIBITOR -> TARGET |
BINDING
|
||
|
|
INHIBITOR -> TARGET |
BINDING
|
||
|
|
LIGAND->TARGET |
Binding studies have demonstrated that ADG20 competes with ACE-2 for binding to SARS-CoV-2 S protein thus preventing viral entry
|
||
|
VECTOR->EXPRESSED PROTEIN |
|
||
|
|
INHIBITOR -> TARGET |
BRII-198 has no or moderately reduced binding activity (approximately two to three-fold) to
human Fc? receptors (Fc?R I, Fc?R IIa, Fc?R IIb, Fc?R IIIa.
BINDING
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|